Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells
- PMID: 16357145
- DOI: 10.1158/0008-5472.CAN-05-1602
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells
Abstract
Aberrant activation of nuclear factor-kappaB (NF-kappaB) transcription factors has been implicated in the pathogenesis of breast cancer. We previously showed elevated activity of IkappaB kinase alpha (IKKalpha), IKKbeta, and protein kinase CK2 in primary human breast cancer specimens and cultured cells. A novel inducible IKK protein termed IKK-i/IKKepsilon has been characterized as a potential NF-kappaB activator. Here, we provide evidence that implicates IKK-i/IKKepsilon in the pathogenesis of breast cancer. We show IKK-i/IKKepsilon expression in primary human breast cancer specimens and carcinogen-induced mouse mammary tumors. Multiple breast cancer cell lines showed higher levels of IKK-i/IKKepsilon and kinase activity compared with untransformed MCF-10F breast epithelial cells. Interestingly, IKK-i/IKKepsilon expression correlated with CK2alpha expression in mammary glands and breast tumors derived from MMTV-CK2alpha transgenic mice. Ectopic CK2 expression in untransformed cells led to increased IKK-i/IKKepsilon mRNA and protein levels. Inhibition of CK2alpha via the pharmacologic inhibitor apigenin or upon transfection of a CK2 kinase-inactive subunit reduced IKK-i/IKKepsilon levels. Expression of a kinase-inactive IKK-i/IKKepsilon mutant in breast cancer cells reduced NF-kappaB activity as judged by transfection assays of reporters driven either by NF-kappaB elements or the promoters of two NF-kappaB target genes, cyclin D1 and relB. Importantly, the kinase-inactive IKK-i/IKKepsilon mutant reduced the endogenous levels of these genes as well as the ability of breast cancer cells to grow in soft agar or form invasive colonies in Matrigel. Thus, CK2 induces functional IKK-i/IKKepsilon, which is an important mediator of the activation of NF-kappaB that plays a critical role in the pathogenesis of breast cancer.
Similar articles
-
Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.Cancer Res. 2001 May 1;61(9):3810-8. Cancer Res. 2001. PMID: 11325857
-
Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.Cancer Res. 2002 Nov 15;62(22):6770-8. Cancer Res. 2002. PMID: 12438279
-
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.Mol Cell Biol. 2005 Nov;25(22):10136-47. doi: 10.1128/MCB.25.22.10136-10147.2005. Mol Cell Biol. 2005. PMID: 16260626 Free PMC article.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.Oncogene. 1999 Nov 22;18(49):6867-74. doi: 10.1038/sj.onc.1203219. Oncogene. 1999. PMID: 10602462 Review.
Cited by
-
Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer.Cancer Manag Res. 2019 Jul 15;11:6593-6602. doi: 10.2147/CMAR.S204924. eCollection 2019. Cancer Manag Res. 2019. PMID: 31406474 Free PMC article.
-
IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.J Biol Chem. 2010 Feb 5;285(6):3676-3684. doi: 10.1074/jbc.M109.078212. Epub 2009 Nov 23. J Biol Chem. 2010. Retraction in: J Biol Chem. 2016 Oct 21;291(43):22857. doi: 10.1074/jbc.A109.078212 PMID: 19940156 Free PMC article. Retracted.
-
Targeting IκappaB kinases for cancer therapy.Semin Cancer Biol. 2019 Jun;56:12-24. doi: 10.1016/j.semcancer.2018.02.007. Epub 2018 Feb 24. Semin Cancer Biol. 2019. PMID: 29486318 Free PMC article. Review.
-
The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth.Carcinogenesis. 2010 Aug;31(8):1319-28. doi: 10.1093/carcin/bgq028. Epub 2010 Jan 27. Carcinogenesis. 2010. PMID: 20106901 Free PMC article. Review.
-
IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer.Cancers (Basel). 2022 Jul 28;14(15):3684. doi: 10.3390/cancers14153684. Cancers (Basel). 2022. PMID: 35954347 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials